ResMed (RMD) Insider Trading & Ownership $274.77 -0.61 (-0.22%) Closing price 08/29/2025 03:59 PM EasternExtended Trading$271.50 -3.27 (-1.19%) As of 08/29/2025 04:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ResMed (NYSE:RMD) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.71%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$38.42M Get RMD Insider Trade Alerts Want to know when executives and insiders are buying or selling ResMed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RMD Insider Buying and Selling by Quarter ResMed Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/18/2025John HernandezDirectorSell2,575$287.10$739,282.50 8/7/2025Michael J FarrellCEOSell8,009$279.48$2,238,355.32 8/1/2025Michael J RiderGeneral CounselSell50$281.90$14,095.00 7/7/2025Michael J FarrellCEOSell8,009$256.72$2,056,070.48 7/2/2025Peter C FarrellDirectorSell945$255.49$241,438.05 6/9/2025Michael J FarrellCEOSell8,009$251.21$2,011,940.89 6/4/2025Kelly MorrisonU.S. Congress Member (D-MN)Sell$249.89$1,001 - $15,0006/2/2025Michael J RiderGeneral CounselSell41$243.78$9,994.98 5/28/2025Ro KhannaU.S. Congress Member (D-CA)Buy$244.66$1,001 - $15,0005/20/2025Witte Jan DeDirectorSell2,000$243.47$486,940.00 5/7/2025Michael J FarrellCEOSell8,009$243.23$1,948,029.07 5/7/2025Peter C FarrellDirectorSell2,000$242.25$484,500.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/28/2025Kelly MorrisonU.S. Congress Member (D-MN)Sell$234.06$1,001 - $15,0004/23/2025Ro KhannaU.S. Congress Member (D-CA)Sell$214.80$1,001 - $15,0004/7/2025Michael J FarrellCEOSell8,009$209.85$1,680,688.65 4/2/2025Peter C FarrellDirectorSell2,000$219.74$439,480.00 4/1/2025Michael J RiderGeneral CounselSell64$222.86$14,263.04 3/10/2025Kaushik GhoshalInsiderSell9,745$239.31$2,332,075.95 3/7/2025Michael J FarrellCEOSell8,009$229.20$1,835,662.80 3/5/2025Peter C FarrellDirectorSell2,000$227.71$455,420.00 3/3/2025Kaushik GhoshalInsiderSell9,113$235.40$2,145,200.20 2/7/2025Michael J FarrellCEOSell8,009$236.77$1,896,290.93 2/5/2025Peter C FarrellDirectorSell2,000$242.11$484,220.00 2/3/2025Michael J RiderGeneral CounselSell64$242.42$15,514.88 1/13/2025Robert Bresnahan, Jr.U.S. Congress Member (R-PA)Sell$230.55$1,001 - $15,00012/4/2024Peter C FarrellDirectorSell2,000$245.65$491,300.00 12/2/2024Michael J RiderGeneral CounselSell74$248.91$18,419.34 11/22/2024Justin LeongInsiderSell6,160$243.09$1,497,434.40 11/12/2024Witte Jan DeDirectorSell796$248.81$198,052.76 11/6/2024Peter C FarrellDirectorSell2,000$248.74$497,480.00 11/1/2024Michael J RiderGeneral CounselSell69$242.00$16,698.00 10/11/2024Kaushik GhoshalInsiderSell4,260$238.48$1,015,924.80 10/8/2024Brett SandercockCFOSell1,000$233.47$233,470.00 10/7/2024Michael J FarrellCEOSell14,683$231.91$3,405,134.53 10/7/2024Michael J FarrellCEOSell14,683$231.91$3,405,134.53 10/2/2024Peter C FarrellDirectorSell2,000$237.20$474,400.00 9/12/2024Kaushik GhoshalInsiderSell5,000$252.56$1,262,800.00 9/9/2024Brett SandercockCFOSell1,000$246.42$246,420.00 9/9/2024Michael J FarrellCEOSell14,683$248.38$3,646,963.54 9/4/2024Peter C FarrellDirectorSell2,000$239.90$479,800.00 (Data available from 1/1/2013 forward) RMD Insider Trading Activity - Frequently Asked Questions Who is on ResMed's Insider Roster? The list of insiders at ResMed includes Brett Sandercock, David Pendarvis, John Hernandez, Justin Leong, Karen Drexler, Kaushik Ghoshal, Lucile Blaise, Michael J Farrell, Michael J Rider, Peter C Farrell, Robert Andrew Douglas, and Witte Jan De. Learn more on insiders at RMD. What percentage of ResMed stock is owned by insiders? 0.71% of ResMed stock is owned by insiders. Learn more on RMD's insider holdings. Which ResMed insiders have been selling company stock? The following insiders have sold RMD shares in the last 24 months: Brett Sandercock ($1,554,070.00), John Hernandez ($739,282.50), Justin Leong ($11,916,794.40), Karen Drexler ($91,341.00), Kaushik Ghoshal ($6,756,000.95), Michael J Farrell ($38,882,447.15), Michael J Rider ($349,190.74), Peter C Farrell ($6,045,425.15), and Witte Jan De ($763,577.16). How much insider selling is happening at ResMed? Insiders have sold a total of 301,761 ResMed shares in the last 24 months for a total of $67,098,129.05 sold. Which members of congress are trading ResMed? Ro Khanna (D-CA) has bought shares of ResMed in the last year totaling $8,000. Kelly Morrison (D-MN), Ro Khanna (D-CA), and Robert Bresnahan, Jr. (R-PA) have sold shares totaling $32,000. ResMed Key ExecutivesMr. Michael J. Farrell BE (Age 52)MBA, SM, CEO & Chairman Compensation: $2.92M6 recent tradesDr. Peter C. Farrell A.M. (Age 82)B.E., BE (Hons), Ph.D., ScD, Founder, Chair Emeritus & Director Compensation: $459.72kMr. Brett A. Sandercock (Age 57)Chief Financial Officer Compensation: $933.66kMr. Michael J. Rider (Age 66)Chief Legal Officer & Secretary Compensation: $854.32k3 recent tradesMr. Justin Leong (Age 47)Chief Product Officer Compensation: $1.2MMr. Kaushik Ghoshal (Age 56)Chief Commercial Officer - SaaS Compensation: $1.23M2 recent tradesMr. Alastair RobertsonChief Information OfficerMs. Amy WakehamChief Investor Relations OfficerMr. Jim EllisChief Compliance OfficerMs. Yvonne-Katrin PucknatChief Marketing Officer More Insider Trading Tools from MarketBeat Related Companies Medpace Insider Trading Encompass Health Insider Trading Hims & Hers Health Insider Trading Boston Scientific Insider Trading Stryker Insider Trading Medtronic Insider Trading Becton, Dickinson and Company Insider Trading IDEXX Laboratories Insider Trading Edwards Lifesciences Insider Trading DexCom Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Costco Faces Downgrades, Death Cross, Insider SellingReynolds Consumer Products Stock Price: Insiders Signal a BottomBuy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say Buy This page (NYSE:RMD) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ResMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ResMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
